Basilea headquarters in Alschil, Switzerland. © Mohamd Ghani - wikipedia.org

Macrocycle library secialist Spexis AG is set to sell a preclinical antibiotics programme afor CHF2m to Basilea Pharmaceutica Ltd.

© Enifer

Microbial production specialist Enifer has secured a €12m grant from Business Finland to build a mycoprotein ingredient factory with a capacity of 300,000 tonnes annually.

Mogu Panels are made from soft, foam-like mycelium materials and of upcycled textile residues. © Mogu Srl

Italian mycelium specialist Mogu Srl has closed a €11m Series A financing co-led by CDP Venture Capital and the  European Circular Bioeconomy Fund (ECBF VC)

Antibiotic resistance tests; the bacteria in the culture on the left are sensitive to the antibiotics contained in the white paper discs. The bacteria on the right are resistant to most of the antibiotics. © Dr Graham Beards  wikipedia.org

Novo Nordisk Foundation has partnered with CARB-X investing US$25m to help SMEs to fight drug-resistant infections.

© Jabri & Abadie Nat.Rev.Immunol 2015; Waldmann et al. J. Exp. Med 2019; Created with BioRender

Calypso Biotech BV has entered into an agreement to be acquired by Novartis AG, which will pay. Calypso’s US$250m upfront upon closing plus of up to US$175.

FDA Building 31 houses the Office of the Commissioner and the Office of Regulatory Affairs. © U.S. Food and Drug Administration

Following in the footsteps of the European Medicines Agency (EMA), the US FDA is now also investigating the side effects of obesity blockbusters.

Boehringer Ingelheim headquarters. © Boehringer Ingelheim

Boehringer Intelheim is expanding its antfibrotics pipeline licencing a first-in-class treatment for fibro-inflammatory diseases from  Kyowa Kirin Co. Ltd.

Brown and white fat cells. © Patrick Seale, University of Pennsylvania School of Medicine/NIH

Italian Resalis Therapeutics Srl has baged €10m in a Series A financing led by Sunstone Life Science Ventures to complete a Phase I study for RES-010 in obesity.

EM picture of A. baumannii. © Vader1941 - wikipedia.org

Hoffmann-La Roche AG has published details on the mechanism of action of its Phase I antibiotic Zosurabalpin (RG6006) that kills the carbapenem-resistant bug Acinetobacter baumannii.
.

In Berlin-Spandau on the site of the historical Prussian rifle factory from the 19th century, HAVEL LABS is emerging as a Work-Life-Place of the future, precisely tailored to the requirements of companies in the Life Science sector. Picture: © bloomimages

With HAVEL LABS, a unique campus is being developed in Berlin-Spandau. ­Spanning over 20,000 m2, this space is designed for forward-thinking work environments. Modern industrial workplaces and logistics concepts, aligned with GMP (Good Manufacturing Practice) ­guidelines, can be ­effortlessly realised on the premises, as can laboratories ranging from safety level S1 to S3 in ­accordance with German Genetic Engineering Safety Regulations.